Grzegorz Kwiatkowski, Aleksandra Kaszlikowska, Laura Seldeslachts, Lauren Michiels, Tadeusz Pałasz, Uwe Himmelreich, Greetje Vande Velde, Stefan Chłopicki
{"title":"Quantitative T<sub>2</sub> mapping of lung parenchyma at 9.4 T: A feasibility study in three murine models of interstitial lung disease.","authors":"Grzegorz Kwiatkowski, Aleksandra Kaszlikowska, Laura Seldeslachts, Lauren Michiels, Tadeusz Pałasz, Uwe Himmelreich, Greetje Vande Velde, Stefan Chłopicki","doi":"10.1002/mrm.30534","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To validate the feasibility of quantitative T<sub>2</sub> mapping as a novel, gadolinium-free, preclinical biomarker of interstitial lung disease (ILD).</p><p><strong>Methods: </strong>Quantitative T<sub>2</sub> mapping of lung parenchyma was obtained with multiple-slice multiple-echo readout. A mono-exponential model of magnetization decay was fit to the data to obtain parametric maps of T<sub>2</sub> relaxation time in four slices across whole lungs. The measurements were performed in three clinically relevant murine models ILD: acute lung injury due to endotoxemia, chronic recovery phase post-influenza infection, and bleomycin-induced interstitial lung fibrosis.</p><p><strong>Results: </strong>Quantitative maps of T<sub>2</sub> relaxation in healthy mice showed a mean value of 10.51 ± 0.56 ms. During ILD development, the mean T<sub>2</sub> increased up to threefold, showing high sensitivity to altered tissue water content due to augmented fraction of macromolecules in fibrosis or inflammation associated with disease progression.</p><p><strong>Conclusion: </strong>T<sub>2</sub> mapping of mouse lungs can be successfully applied at 9.4 T, offering quantitative insights through parametric T<sub>2</sub> mapping across various ILD models without requiring contrast agents. The proposed method for evaluating lung tissue damage is adaptable to other interstitial lung diseases.</p>","PeriodicalId":18065,"journal":{"name":"Magnetic Resonance in Medicine","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Magnetic Resonance in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/mrm.30534","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To validate the feasibility of quantitative T2 mapping as a novel, gadolinium-free, preclinical biomarker of interstitial lung disease (ILD).
Methods: Quantitative T2 mapping of lung parenchyma was obtained with multiple-slice multiple-echo readout. A mono-exponential model of magnetization decay was fit to the data to obtain parametric maps of T2 relaxation time in four slices across whole lungs. The measurements were performed in three clinically relevant murine models ILD: acute lung injury due to endotoxemia, chronic recovery phase post-influenza infection, and bleomycin-induced interstitial lung fibrosis.
Results: Quantitative maps of T2 relaxation in healthy mice showed a mean value of 10.51 ± 0.56 ms. During ILD development, the mean T2 increased up to threefold, showing high sensitivity to altered tissue water content due to augmented fraction of macromolecules in fibrosis or inflammation associated with disease progression.
Conclusion: T2 mapping of mouse lungs can be successfully applied at 9.4 T, offering quantitative insights through parametric T2 mapping across various ILD models without requiring contrast agents. The proposed method for evaluating lung tissue damage is adaptable to other interstitial lung diseases.
期刊介绍:
Magnetic Resonance in Medicine (Magn Reson Med) is an international journal devoted to the publication of original investigations concerned with all aspects of the development and use of nuclear magnetic resonance and electron paramagnetic resonance techniques for medical applications. Reports of original investigations in the areas of mathematics, computing, engineering, physics, biophysics, chemistry, biochemistry, and physiology directly relevant to magnetic resonance will be accepted, as well as methodology-oriented clinical studies.